ZLAB vs XENE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ZLAB

61.1
AI Score
VS
ZLAB Wins

XENE

60.3
AI Score

Investment Advisor Scores

ZLAB

61score
Recommendation
BUY

XENE

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZLAB XENE Winner
Revenue 205.92M 264,000 ZLAB
Net Income -101.84M -22.64M XENE
Net Margin -49.5% -8575.4% ZLAB
Operating Income -145.87M -24.52M XENE
ROE -16.8% -52.3% ZLAB
ROA -9.5% -48.8% ZLAB
Total Assets 1.07B 46.36M ZLAB
Cash 607.52M 14.69M ZLAB
Free Cash Flow -77.82M -22.14M XENE

Relative Price Performance (Last 90 Days)

ZLAB 1M: -8.4% · 3M: +23.0% XENE 1M: -8.0% · 3M: -45.0%

Current Technical Phase

ZLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $24.20

XENE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.0%), weak momentum, RSI 34

RSI (14): 33.9 · Price: $35.95

Fundamentals Snapshot

Metric ZLAB XENE
Market Cap — —
Forward P/E -11.5 -7.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin 0.0% —
Operating Margin -0.7% 0.0%
EPS -1.70 -4.74
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZLAB is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.